Fresenius Kabi Expands in Indonesia with Soho Group Joint Venture

By Heather Cartwright

Pharma Deals Review: Vol 2013 Issue 8 (Table of Contents)

Published: 24 Aug-2013

DOI: 10.3833/pdr.v2013.i8.1974     ISSN: 1756-7874

Section: Joint Venture

Fulltext:

Abstract

Fresenius Kabi has moved to gain a sizeable presence in the fast-growing Indonesian pharmaceutical market by agreeing to form a joint venture with Soho Group, the fourth largest pharmaceutical company in Indonesia, by taking a 51% stake in its PT Ethica Industri Farmasi subsidiary...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details